Researchers from the First Medical Center of Chinese PLA General Hospital, Zhengzhou University, and other institutions conducted a study titled “Epigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer”. This study was published in Frontiers of Medicine, Volume 18, Issue 4.
